Antibiotic sensitivity profile of bacterial pathogens in postoperative wound infections at a tertiary care hospital in Gujarat, India

Journal of Pharmacology and Pharmacotherapeutics

Volumn 2, Issue 3, 2011, Pages 158-164

  Goswami, Nutanbala N ^a   Trivedi, Hiren R ^b   Goswami, Alpesh Puri P ^a   Patel, Tejas K ^a   Tripathi, C B ^a  

^a GOVERNMENT MEDICAL COLLEGE   (India)

^b M P SHAH MEDICAL COLLEGE   (India)

Author keywords

Antibiogram; antibiotic sensitivity; bacterial resistance; gram negative bacteria; gram positive bacteria

Indexed keywords

AMIKACIN; AMPICILLIN; CEFADROXIL; CEFDINIR; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; CLINDAMYCIN; CLOXACILLIN; COTRIMOXAZOLE; GATIFLOXACIN; GENTAMICIN; LEVOFLOXACIN; LINEZOLID; MEROPENEM; METRONIDAZOLE; NORFLOXACIN; PENICILLIN G; RIFAMPICIN; SULTAMICILLIN; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; BACTERIAL VIRULENCE; BACTERIUM CULTURE; BACTERIUM ISOLATION; DISK DIFFUSION; ESCHERICHIA COLI; FEMALE; HUMAN; IN VITRO STUDY; INDIA; INFECTION PREVENTION; INFECTION RATE; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; OBSERVATIONAL STUDY; PROSPECTIVE STUDY; PROTEUS MIRABILIS; PROTEUS VULGARIS; PSEUDOMONAS AERUGINOSA; REVIEW; SEX DIFFERENCE; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; SURGICAL INFECTION; TERTIARY HEALTH CARE;

EID: 84858970309     PISSN: 0976500X     EISSN: None     Source Type: Journal    
DOI: 10.4103/0976-500X.83279     Document Type: Review

References (37)

1. Ashby E, Haddad FS, O'Donnell E, Wilson A P. How will surgical site infection be measured to ensure "high quality care for all"? J Bone Joint Surg Br 2010;92:1294-9.
2. Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 1999;20:250-78.
3. Tiwari HK, Sen MR. Emergence of vancomycin resistant Staphylococcus aureus from a tertiary care hospital from northern part of India. BMC Infect Dis 2006;6:156.
4. Hemant Singhal, Kanchan Kaur. Wound infection. Overview: History. The ancient Egyptians were the first civilization to have trained clinicians to treat physical aliments. eMed General Surg 2009. Surg Infect (Larchmt) 2009;10:323-31.
5. Chastre J, Trouillet JL. Problem pathogens (Pseudomonas aeruginosa and Acinetobacter). Semin Respir Infect 2000;15:287-98.
6. Obritsch MD, Fish DN, McLaren R, Jung R. National Surveillance of Antimicrobial Resistance in Pseudomonas aeruginosa isolates obtained from Intensive Care Unit Patients from 1993 to 2002. Antimicrob Agents Chemother 2004;48:4606-10.
7. Rubin RH. Surgical wound infection: Epidemiology, pathogenesis, diagnosis and management. BMC Infect Dis 2006;6:171.
8. nd ed. World Health Organization, Department of Communicable Disease, Surveillance and response. Available from: http://apps.who.int/medicinedocs/documents/s16355e/s16355e.pdf. [Last cited on 2010 Nov 03].
9. Zhanel GG, DeCorby M, Laing N, Weshnoweski B, Vashisht R, Tailor F, et al. Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006. Antimicrob Agents Chemother 2008;52:1430-7.
10. Hasselgren PO, Saljo A, Fornander J, Lundstam S, Saretok T, Seeman T. Postoperative wound infections- a prospective study in a newly opened hospital. Ann Chir Gynaecol 1980;69:269-72.
11. Mathew A. Wkler, Franklin R. Cockerill, Karen Bush, Michael N. Dudley, George M. Etiopoule, Dhright J. Hardy, et al. Clinical and laboratory standard institute. Performance standards for an antimicrobial disc susceptibility tests; Approved standard. 10th ed. Available from: http://www.clsi.org/source/orders/ free/m02-a10.pdf. [Last cited on 2010 Nov 03].
12. Suchitra JB, Lakshmidevi N. Surgical site infestions. Assessing risk factors and antimicrobial sensitivity patterns. Afr J Microbiol Res 2009;3:185-9. Available from: http://www.academicjournals.org/ajmr. [Last cited on 2010 Nov 03].
13. Abu Hanifah Y. Post-operative surgical wound infection. Med J Malaysia 1990;45:293-7.
14. Malone DL, Genuit T, Tracy JK, Gannon C, Napolitano LM. Surgical site infections. Reanalysis of risk Factors. J Surg Res 2002;103:89-95.
15. Surucuoglu S, Gazi H, Kurutepe S, Ozkutuk N, Ozbakkaloglu B. Bacteriology of surgical wound infections in a tertiary care hospital in Turkey. East Afr Med J 2005;82:331-6.
16. Thanni LO, Osinupebi OA, Deji-Agboola M. Prevalence of bacterial pathogens in infected wounds in a tertiary hospital, 1995-2001: any change in trend? J Natl Med Assoc 2003;95:1189-95.
17. Giacometti A, Cicrioni O, Schimizzi AM, Delprete MS, Barchiesi F, D'Errico MM, et al. Epidemiology and Microbiology of Surgical Wound infections. J Clin Microbiol 2000;38:918-22.
18. Weber SG, Miller RR, pereneevich EN, Tolentino J, Meltzer D, Pitrak D, et al. Prevalence of antimicrobial resistant bacteria isolated from older versus younger hospitalized adults: Results of a two centre study. J Antimicrob Chemother 2009; 64:1291-8.
19. Siegrist HH, Nepa MC, Jacquet A. Susceptibility to Levofloxacin of clinical isolates of bacteria from intensive care and hematological/oncology patients in Switzerland: a multicentre study. J Antimicrob Chemother 1999;43:51-4.
20. Kaufman D, Haas CE, Edinger R, Hollick G. Antibiotic Susceptibility in the Surgical Intensive Care Unit Compared With the Hospital-Wide Antibiogram. Arch Surg 1998;133:1041-5.
21. Schmitz FJ, Fluit AC, Gondolf M, Beyrau R, Lindenlauf E, Verhoef J, et al. The prevalence of aminoglycoside resistance and corresponding resistance genes in clinical isolates of Staphylococci from 19 European hospitals. J Antimicrob Chemother 1999;43:253-9.
22. Tiwari HK, Sen MR. Emergence of vancomycin resistant Staphylococcus aureus (VRSA) from a tertiary care hospital from northern part of India. BMC Infect Dis 2006;6:156.
23. David EB, Edward RA, Carl AB. Fundamentals Of Molecular Diagnostic - Google Books Result - 2007 - Medical - 267 pages. There have been few cases of infection by VRSA reported in the United⋯ the possibility of false-positive results in mixed cultures of S. aureus and CoNS⋯ available from: http://www.books.google.co.in/books?isbn=1416037373..... [Last cited on 2010 Nov 03].
24. Andrews JM. The development of the BSAC standardized method of disc diffusion testing. J Antimicrob Chemother 2001;48:29-42.
25. Hiramatsu K, Aritaka N, Hanaki H, Kawasaki S, Hori S, Hosoda Y, et al. Dissemiantion in Japanese Hospitals of strains of Staphylkococcus aureus heterogeneously resistant to vancomycin. Lancet 1997;350:1670-3.
26. Howe RA, Wootton M, Bennett PM, Mac Gowan A P, Walsh TR. Interactions between methicillin and vancomycin in methicillin resistant Staphylococcus aureus strains displaying different phenotypes of vancomycin susceptibility. J Clin Microbol 1999;37:3068-71.
27. Wootton M, Walsh TR, Howe RA, White G, Andrews JM, Wise R. Methodological factors in the detection of heterogeneously vancomycin resistant Staphylococcus aureus (h VRSA). San Diego, CA, USA: Program and Abstracts of the Thirty- eighth Interscience Conference on Antimicrobial Agents and Chemotherapy; Abstract C-139. Washington DC: American Society for Microbiology; 1996, Abstract C-139, p. 108.
28. Iyer RN, Hittinahalli V. Modified PAP method to detect heteroresistance to vancomycin among methicillin resistant Staphylococcus aureus isolates at a tertiary care hospital. Indian J Med Microbiol 2008;26:176-9.
29. Burnham CA, Weber CJ, Michael WM Jr. Novel Screening Agar for Detection of Vancomycin-Nonsusceptible Staphylococcus aureus. J Clin Microbiol 2010;48:949-51.
30. Van Eldere J. Multicentre surveillance of Pseudomonas aeruginosa susceptibility patterns in nosocomial infections. J Antimicrob Chemother 2003;51:347-52.
31. Gales AC, Jones RN, Turnidge J, Rennie R, Ramphal R. Characterization of Pseudomonas aeruginosa: occurrence rate, antimicrobial susceptibility pattern and molecular typing in the global sentry antimicrobial surveillance program 1997-1999. Clinic Infect Dis 2001:32;S146-55.
32. Jonas RN. Resistance pattern among nosocomial pathogens: trends over the past few years. Chest 2001;119:397S-404S.
33. Fadeyi A, Akanbi AA 2nd, Nwabuisi C, Onile BA. Antibiotic disc sensitivity pattern of Pseudomonas aeruginosa isolates obtained from clinical specimen in Ilorin, Nigeria. Afr J Med 2005;34:303-6.
34. Raja NS, Singh NN. Antimicrobial susceptibility pattern of clinical isolates of Pseudomonas aeruginosa in tertiary care hospital. J Microbiol Immunol Infect 2007;40:45-9.
35. Bertrand XM, Thouverez M, Patry C, Balvay P, Talon D. Pseudomonas aeruginosa: Antibiotic susceptibility and genotypic characterization of strains isolated in the intensive care unit. Clin Microbiol Infect 2002;7:706-8.
36. Clark NM, Patterson J, Lynch JP 3rd. Antimicrobial resistance among gramnegative organisms in the intensive care unit. Curr OpinCrit Care 2003;9:413-23.
37. Sweeney M T, Zurenko GE. In vitro activities of linezolid combined with other antimicrobial agents against staphylococci, enterococci, pneumococci, and selected gram-negative organisms. Antimicrob Agents Chemother 2003;47:1902-6.